Xenetic Biosciences (XBIO) Competitors $3.60 +0.50 (+16.13%) Closing price 09/12/2025 03:55 PM EasternExtended Trading$3.56 -0.04 (-1.22%) As of 09/12/2025 06:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIO vs. LEXX, LSB, CYCC, SYBX, AIMD, HOTH, ATNF, EDSA, MTEX, and ETHZShould you be buying Xenetic Biosciences stock or one of its competitors? The main competitors of Xenetic Biosciences include Lexaria Bioscience (LEXX), LakeShore Biopharma (LSB), Cyclacel Pharmaceuticals (CYCC), Synlogic (SYBX), Ainos (AIMD), Hoth Therapeutics (HOTH), 180 Life Sciences (ATNF), Edesa Biotech (EDSA), Mannatech (MTEX), and Flag Ship Acquisition (ETHZ). These companies are all part of the "pharmaceutical products" industry. Xenetic Biosciences vs. Its Competitors Lexaria Bioscience LakeShore Biopharma Cyclacel Pharmaceuticals Synlogic Ainos Hoth Therapeutics 180 Life Sciences Edesa Biotech Mannatech Flag Ship Acquisition Xenetic Biosciences (NASDAQ:XBIO) and Lexaria Bioscience (NASDAQ:LEXX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership. Do analysts recommend XBIO or LEXX? Lexaria Bioscience has a consensus price target of $4.00, indicating a potential upside of 236.13%. Given Lexaria Bioscience's stronger consensus rating and higher probable upside, analysts plainly believe Lexaria Bioscience is more favorable than Xenetic Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Xenetic Biosciences 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Lexaria Bioscience 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders & institutionals have more ownership in XBIO or LEXX? 15.1% of Xenetic Biosciences shares are held by institutional investors. Comparatively, 13.1% of Lexaria Bioscience shares are held by institutional investors. 14.7% of Xenetic Biosciences shares are held by insiders. Comparatively, 26.4% of Lexaria Bioscience shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more risk and volatility, XBIO or LEXX? Xenetic Biosciences has a beta of 2.43, indicating that its share price is 143% more volatile than the S&P 500. Comparatively, Lexaria Bioscience has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Is XBIO or LEXX more profitable? Xenetic Biosciences has a net margin of -126.08% compared to Lexaria Bioscience's net margin of -1,849.19%. Xenetic Biosciences' return on equity of -54.56% beat Lexaria Bioscience's return on equity.Company Net Margins Return on Equity Return on Assets Xenetic Biosciences-126.08% -54.56% -47.28% Lexaria Bioscience -1,849.19%-157.22%-133.69% Does the media prefer XBIO or LEXX? In the previous week, Xenetic Biosciences and Xenetic Biosciences both had 2 articles in the media. Lexaria Bioscience's average media sentiment score of 1.45 beat Xenetic Biosciences' score of 1.44 indicating that Lexaria Bioscience is being referred to more favorably in the news media. Company Overall Sentiment Xenetic Biosciences Positive Lexaria Bioscience Positive Which has higher earnings and valuation, XBIO or LEXX? Xenetic Biosciences has higher revenue and earnings than Lexaria Bioscience. Xenetic Biosciences is trading at a lower price-to-earnings ratio than Lexaria Bioscience, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioXenetic Biosciences$2.50M2.22-$3.96M-$2.00-1.80Lexaria Bioscience$460K50.60-$5.80M-$0.67-1.78 SummaryLexaria Bioscience beats Xenetic Biosciences on 8 of the 15 factors compared between the two stocks. Get Xenetic Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding XBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIO vs. The Competition Export to ExcelMetricXenetic BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.78M$2.59B$5.87B$10.13BDividend YieldN/A56.52%5.68%4.60%P/E Ratio-1.8023.5374.5225.93Price / Sales2.22523.61517.44183.79Price / CashN/A171.1637.5660.44Price / Book0.935.3712.166.29Net Income-$3.96M$32.95M$3.28B$270.77M7 Day Performance18.62%1.28%0.87%3.88%1 Month Performance20.40%6.09%4.96%4.88%1 Year Performance-9.79%-2.15%60.75%26.01% Xenetic Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBIOXenetic Biosciences1.3148 of 5 stars$3.60+16.1%N/A-6.5%$4.78M$2.50M-1.804Positive NewsHigh Trading VolumeLEXXLexaria Bioscience3.8814 of 5 stars$0.89+0.6%$4.00+351.5%-66.2%$17.33M$460K-1.327Positive NewsShort Interest ↓LSBLakeShore Biopharma1.2755 of 5 stars$0.83+3.7%N/A-84.1%$17.24M$85.67M0.00773News CoverageShort Interest ↓Gap DownCYCCCyclacel Pharmaceuticals0.423 of 5 stars$7.69-6.6%N/A-97.5%$17.23M$40K-0.0114Short Interest ↑SYBXSynlogic1.6544 of 5 stars$1.46+0.7%N/A+12.4%$17.08M$10K-18.2580Short Interest ↓AIMDAinos1.0369 of 5 stars$3.66-4.2%N/A+37.7%$17.06M$20K-0.7340HOTHHoth Therapeutics2.843 of 5 stars$1.28+10.3%$4.00+212.5%+41.6%$16.97MN/A-1.204Analyst UpgradeShort Interest ↓High Trading VolumeATNF180 Life Sciences0.2015 of 5 stars$2.81-2.1%N/A+21.1%$16.97MN/A-0.197EDSAEdesa Biotech1.439 of 5 stars$2.34+0.9%$5.00+113.7%-44.5%$16.47MN/A-1.7720MTEXMannatech1.0076 of 5 stars$8.60-10.2%N/A+7.9%$16.34M$117.87M-4.22250News CoverageShort Interest ↓ETHZFlag Ship AcquisitionN/A$2.67-5.0%N/AN/A$16.13MN/A-0.187Positive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies LEXX Competitors LSB Competitors CYCC Competitors SYBX Competitors AIMD Competitors HOTH Competitors ATNF Competitors EDSA Competitors MTEX Competitors ETHZ Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBIO Stock Alerts